Stevanato Group S.p.A. (STVN)
Automate Your Wheel Strategy on STVN
With Tiblio's Option Bot, you can configure your own wheel strategy including STVN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STVN
- Rev/Share 4.1211
- Book/Share 5.1884
- PB 4.0493
- Debt/Equity 0.2778
- CurrentRatio 1.825
- ROIC 0.0649
- MktCap 5733169078.6944
- FreeCF/Share -0.3614
- PFCF -58.1339
- PE 45.6895
- Debt/Assets 0.1692
- DivYield 0.0025
- ROE 0.0918
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | STVN | Wolfe Research | -- | Outperform | -- | $28 | Dec. 13, 2024 |
| Resumed | STVN | Morgan Stanley | -- | Equal Weight | -- | $23 | Dec. 3, 2024 |
News
GRFS vs. STVN: Which Stock Is the Better Value Option?
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Stevanato Group (STVN) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.09 per share a year ago.
Read More
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript
Published: March 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Stevanato Group S.p.A. (NYSE:STVN ) Q4 2024 Earnings Conference Call March 6, 2025 8:30 AM ET Company Participants Lisa Miles - SVP, IR Franco Stevanato - Chairman and CEO Marco Dal Lago - CFO Conference Call Participants Michael Ryskin - Bank of America Matt Larew - William Blair Patrick Donnelly - Citi David Windley - Jefferies Pete Lukas - CJS Securities Anna Snopkowski - KeyBanc Tejas Savant - Morgan Stanley Doug Schenkel - Wolfe Research Operator Good afternoon.
Read More
USNA or STVN: Which Is the Better Value Stock Right Now?
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Read More
About Stevanato Group S.p.A. (STVN)
- IPO Date 2021-07-16
- Website https://www.stevanatogroup.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Franco Stevanato
- Employees 5521